| 1 (28) | Samsung Corp * | MUL |  |
| 2 (72) | AstraZeneca * | MUL |  |
| 3 (73) | F Hoffmann-La Roche * | MUL |  |
| 4 (100) | Hoffmann-La Roche Ltd, United States | USA |  |
| 5 (103) | Bristol-Myers Squibb Company, United States | USA |  |
| 6 (107) | Bristol-Myers Squibb Company * | MUL |  |
| 6 (107) | Genentech Inc | USA |  |
| 6 (107) | Hoffmann-La Roche, GmbH., Germany | DEU |  |
| 6 (107) | Novartis Institutes for Biomedical Research, United States | USA |  |
| 10 (121) | Daiichi Sankyo Co., Ltd. Japan | JPN |  |
| 11 (124) | AbbVie * | MUL |  |
| 12 (125) | AbbVie Inc, United States | USA |  |
| 13 (132) | Regeneron Pharmaceuticals Inc | USA |  |
| 14 (138) | Merck * | MUL |  |
| 15 (153) | AstraZeneca, United Kingdom | GBR |  |
| 16 (155) | AstraZeneca, United States | USA |  |
| 17 (168) | Merck & Co Inc, United States | USA |  |
| 18 (175) | Johnson & Johnson * | MUL |  |
| 19 (177) | Novartis * | MUL |  |
| 20 (189) | Pfizer Inc, United States | USA |  |
| 21 (190) | Pfizer * | MUL |  |
| 21 (190) | Daiichi Sankyo Co., Ltd. * | MUL |  |
| 23 (191) | Eli Lilly and Company, United States | USA |  |
| 23 (191) | Janssen | MUL |  |
| 25 (199) | Janssen Biotech Inc | USA |  |
| 26 (202) | Eli Lilly * | MUL |  |
| 27 (209) | Bayer AG, Germany | DEU |  |
| 27 (209) | Merck KGaA, Germany | DEU |  |
| 29 (218) | Philips Research, Eindhoven | NLD |  |
| 30 (226) | Foundation Medicine Inc | USA |  |
| 31 (234) | Bayer * | MUL |  |
| 32 (237) | Gilead Sciences Inc, United States | USA |  |
| 33 (250) | Gilead Sciences * | MUL |  |
| 34 (275) | Amgen * | MUL |  |
| 35 (295) | Hoffmann-La Roche Ltd, Switzerland | CHE |  |
| 36 (328) | General Electric Company * | MUL |  |
| 37 (342) | Takeda Pharmaceuticals International Inc * | MUL |  |
| 38 (343) | Celgene Corp | USA |  |
| 39 (354) | Amgen, USA | USA |  |
| 40 (364) | Boehringer Ingelheim * | MUL |  |
| 41 (367) | Siemens * | MUL |  |
| 42 (382) | Takeda Pharmaceuticals International Inc, USA | USA |  |
| 42 (382) | GlaxoSmithKline * | MUL |  |
| 44 (386) | Koninklijke Philips NV * | MUL |  |
| 45 (409) | Novartis, Switzerland | CHE |  |
| 46 (416) | GlaxoSmithKline, United States | USA |  |
| 47 (419) | Translational Research Institute | AUS |  |
| 48 (458) | Novartis Pharmaceuticals, United States | USA |  |
| 49 (475) | Sanofi * | MUL |  |
| 50 (479) | Boehringer Ingelheim GmbH Germany | DEU |  |
| 51 (485) | Janssen Research & Development, LLC | BEL |  |
| 52 (506) | Sanofi, United States | USA |  |
| 53 (515) | Siemens AG, Germany | DEU |  |
| 54 (532) | GE Healthcare | MUL |  |
| 55 (542) | Novo Nordisk * | MUL |  |
| 56 (551) | Bayer Corp, USA | USA |  |
| 57 (553) | Novo Nordisk A/S | DNK |  |
| 58 (708) | GE Healthcare China Co Ltd | CHN |  |
| 59 (732) | Manipal Global Education Group * | MUL |  |
| 60 (783) | RTI Health Solutions | USA |  |
|